![Kate Chevlen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kate Chevlen
Corporate Officer/Principal bij
SPYRE THERAPEUTICS, INC.
Profiel
Kate Tansey Chevlen currently works at Spyre Therapeutics, Inc., as Chief Commercial Officer from 2026.
Ms. Chevlen also formerly worked at Amgen, Inc., as VP & Global Marketing Head-Immunology.
Ms. Chevlen received her undergraduate degree from Brandeis University and Masters Business Admin degree from Johnson Graduate School of Management.
Actieve functies van Kate Chevlen
| Bedrijven | Functie | Begin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Corporate Officer/Principal | 12-01-2026 |
Eerdere bekende functies van Kate Chevlen
| Bedrijven | Functie | Einde |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01-01-2026 |
Opleiding van Kate Chevlen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
25
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
